Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease.Journal of clinical medicine · 2019
   Article
2. Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients.Jundishapur journal of microbiology · 2014
   Article
3. Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.Cell journal · 2014
   Article
4. Suppressive impact of anethum graveolens consumption on biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits.International journal of preventive medicine · 2013
   Article
5. Oxidative stress and the paradoxical effects of antioxidants.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
   Article
6. The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
   Article
7. Renoprotective effects of metformin.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2013
   Article
8. Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients.International journal of preventive medicine · 2013
   Article
9. Commentary on: The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
   Article
10. Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2013
    Article
11. Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study.International journal of preventive medicine · 2013
    Article
12. Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
13. Association of serum uric acid with proteinuria in type 2 diabetic patients.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
14. World kidney day 2013: acute kidney injury; a public health aware.Iranian journal of public health · 2013
    Article
15. Reply: oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats.Annals of Saudi medicine
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as